Cannador is a standardized cannabis-based medicinal product containing a controlled ratio of Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD). It is derived from whole-plant cannabis extracts and is formulated in capsules for oral administration. Cannador is mainly used in clinical research and treatment of conditions including multiple sclerosis (MS)-related spasticity and chronic pain. Its standardized composition ensures consistent dosing and therapeutic effects. It is grouped under the following drug class(es): Cannabinoids. The directory classifies it as a discontinued API with a natural source/manufacturing origin. Other names for this substance include UNII-K4H93P747O and Nabiximols. It is listed as a controlled drug substance (Schedule I). Its PubChem CID is 44148067.
Cannador
| CAS No | 56575-23-6 |
|---|---|
| Molecular Formula | C42H60O4 |
| Molecular Weight | 628.9 g/mol |
| Synonyms | (6aR,10aR)-6,6,9-trimethyl-3-pentyl-6a,7,8,10a-tetrahydrobenzo[c]chromen-1-ol;2-[(6R)-3-methyl-6-prop-1-en-2-ylcyclohex-2-en-1-yl]-5-pentylbenzene-1,3-diol |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Cannador is a standardized cannabis-based medicinal product containing a controlled ratio of Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD). It is derived from whole-plant cannabis extracts and is formulated in capsules for oral administration.
The listed CAS number is 56575-23-6.
The listed molecular formula is C42H60O4.
The listed molecular weight is 628.9 g/mol.
(6aR,10aR)-6,6,9-trimethyl-3-pentyl-6a,7,8,10a-tetrahydrobenzo[c]chromen-1-ol;2-[(6R)-3-methyl-6-prop-1-en-2-ylcyclohex-2-en-1-yl]-5-pentylbenzene-1,3-diol.
The source lists UNII-K4H93P747O and Nabiximols.